Christopher J. Senner sold $1.1M of Exelixis (EXEL)

Executed Feb 24 2025, disclosed Feb 26 2025, 2 days later.

Value, as filed

$1.1M

29,314 sh × $36.14

Executed

Feb 24 2025

the trade date, as filed

Disclosed

Feb 26 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CS Christopher J. Senner EVP and CFO profile →

Christopher J. Senner (EVP and CFO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Exelixis, Inc. (EXEL). The largest single filing was $2.8M of EXEL (64,895 sh across 2 lots, as filed), executed Feb 13.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher J. Senner in EXEL

EXELSALE Exelixis, Inc. $1.7M
34,901 sh × $50.00
Exec May 18
Filed May 19 · 5:30 PM ET EXELSALE Exelixis, Inc. $2.8M
64,895 sh across 2 lots
Exec Feb 13
Filed Feb 18 · 5:30 PM ET EXELSALE Exelixis, Inc. $4.6M
100,000 sh × $46.00
Exec May 16 2025
Filed May 16 2025 · 5:30 PM ET